Gildas Prié

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Chronic Myeloid Leukemia

Childhood Cancer

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Victoir, Cécile Croix, Fabrice Gouilleux, Gildas Prié
Targeted Therapeutic Strategies for the Treatment of Cancer. Cancers 16 (2) (2024)
Benjamin Victoir, Cécile Croix, Fabrice Gouilleux, Gildas Prié
Targeted Therapeutic Strategies for the Treatment of Cancer. Cancers 16 (2) (2024)
Marion Polomski, Marie Brachet-Botineau, Ludovic Juen, Marie-Claude Viaud-Massuard, Fabrice Gouilleux, Gildas Prié
Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential. ChemMedChem 16 (6) (2021)
Marie Brachet-Botineau, Marion Polomski, Heidi A Neubauer, Ludovic Juen, Damien Hédou, Marie-Claude Viaud-Massuard, Gildas Prié, Fabrice Gouilleux
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers. Cancers 12 (1) (2020)
Marie Brachet-Botineau, Margaux Deynoux, Nicolas Vallet, Marion Polomski, Ludovic Juen, Olivier Herault, Fréderic Mazurier, Marie-Claude Viaud-Massuard, Gildas Prié, Fabrice Gouilleux
A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells. Cancers 11 (12) (2019)
Ludovic Juen, Marie Brachet-Botineau, Cécile Parmenon, Jérôme Bourgeais, Olivier Hérault, Fabrice Gouilleux, Marie-Claude Viaud-Massuard, Gildas Prié
New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias. Journal of medicinal chemistry 60 (14) (2017)